Aptorum Group Ltd
NASDAQ:APM

Watchlist Manager
Aptorum Group Ltd Logo
Aptorum Group Ltd
NASDAQ:APM
Watchlist
Price: 0.89 USD -6% Market Closed
Market Cap: $7.2m

Profitability Summary

Aptorum Group Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Aptorum Group Ltd

Margins Comparison
Aptorum Group Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Aptorum Group Ltd
NASDAQ:APM
7.2m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
398.8B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.3B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
177.3B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.5B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.7B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.5B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Aptorum Group Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Aptorum Group Ltd
NASDAQ:APM
7.2m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
398.8B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.3B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
177.3B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.5B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
86.7B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.5B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Aptorum Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate